Your browser doesn't support javascript.
loading
Savolitinib monotherapy exerted significant benefit in a non-small cell lung cancer patient with osimertinib resistance harboring primary EGFR L858R mutation and MET amplification: a case report.
Ma, Pei; Huang, Ruohan; Gu, Yunru; Fang, Yuan; Wu, Xi; Chen, Dong-Sheng; Zhang, Han-Wu; Gao, Wen; Shu, Yongqian.
Afiliación
  • Ma P; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Huang R; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Gu Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Fang Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Wu X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Chen DS; Jiangsu Simcere Diagnostics Co., Ltd, The State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
  • Zhang HW; Jiangsu Simcere Diagnostics Co., Ltd, The State Key Laboratory of Translational Medicine and Innovative Drug Development, Nanjing, China.
  • Gao W; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
  • Shu Y; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University.
Anticancer Drugs ; 33(10): 1186-1190, 2022 11 01.
Article en En | MEDLINE | ID: mdl-35946569
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Límite: Humans / Male / Middle aged Idioma: En Revista: Anticancer Drugs Asunto de la revista: ANTINEOPLASICOS Año: 2022 Tipo del documento: Article